Second-quarter earnings more than doubled at US health-care product maker Johnson & Johnson, the company has said.
Quarterly net income was $3.8 billion, or $1.3 a share. The New Jersey—based company attributed the higher earnings in part to the sale of its stake in Elan Corporation.
Revenue rose 8.5 per cent to $17.8 billion year-on-year.
Both earnings and revenue beat Wall Street’s expectations, Bloomberg news reported.